TY - JOUR AU - N., MURUGAN AU - S., PRATHIBA AU - ABHAYA, MAYUR AU - FUJITA, ANSCIN A. PY - 2020/11/01 Y2 - 2024/03/29 TI - COVID-19: AN UPDATE ON THE EPIDEMIOLOGICAL STATUS OF SOUTH INDIA JF - International Journal of Pharmacy and Pharmaceutical Sciences JA - Int J Pharm Pharm Sci VL - 12 IS - 11 SE - Review Article(s) DO - 10.22159/ijpps.2020v12i11.39265 UR - https://journals.innovareacademics.in/index.php/ijpps/article/view/39265 SP - 15-18 AB - <p>Global emergency due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2) and associated COVID-19 necessitates an engaged, integrated, interdisciplinary, and rapid response from the scientific community. India has had 4ยท4 million cases of COVID-19, the second most in the world after the USA, with 75,062 officially confirmed deaths from the disease as of Sept 10, 2020. Total of 27,688,740 confirmed cases and 8, 99,315 death cases were reported as per WHO on Sept 10, 2020 at 10.28 AM, CEST. The United States of America, India, Brazil and Russia recorded the highest cases in the world. We describe here, the outbreak of COVID-19 among the five major South Indian states and the data were collected from various Government authorised websites and the same were comparatively studied among five different states from March to July 15, 2020. In south India, Tamil Nadu reports the highest cases when compared to other states and the least cases were found to be among the state of Kerala as per the study period.</p> ER -